China’s AI, robotics and innovative drug sectors—dubbed the "new-new three"—have expanded rapidly this year, advancing Chinese manufacturing toward higher value-added output. Weekly call volumes for Chinese large AI models have risen for eight consecutive weeks and have ranked first globally for 12 straight weeks. In 1H, China’s robot exports reached 6.29 bln yuan to 141 countries and regions; surgical robot exports rose 3.3-fold. In 1H, outbound licensing and deal activity for Chinese innovativ

China’s AI, robotics and innovative drug sectors—dubbed the "new-new three"—have expanded rapidly this year, advancing Chinese manufacturing toward higher value-added output. Weekly call volumes for Chinese large AI models have risen for eight consecutive weeks and have ranked first globally for 12 straight weeks. In 1H, China’s robot exports reached 6.29 bln yuan to 141 countries and regions; surgical robot exports rose 3.3-fold. In 1H, outbound licensing and deal activity for Chinese innovative drugs totaled about $110 bln, and Chinese firms accounted for eight of the top 10 global pharma deals.